Pharma giants like Novartis and Sanofi are downsizing or exiting India, challenged by local competition & patent expiries. Novartis is evaluating its 70.68% stake in its Indian subsidiary, while Sanofi sold its nutraceuticals business. This trend underscores the difficulties MNCs face in India's growing but competitive pharmaceutical market highlighting a shift towards focusing on core operations.